Corcept Therapeutics
Clinical trials sponsored by Corcept Therapeutics, explained in plain language.
-
New drug trial targets root cause of Cushing's syndrome symptoms
Disease control CompletedThis study tested whether a drug called relacorilant could help control the symptoms of Cushing's syndrome, a condition where the body makes too much of the stress hormone cortisol. The trial involved 137 adults with adrenal tumors, high blood pressure, and/or diabetes. Participa…
Phase: PHASE3 • Sponsor: Corcept Therapeutics • Aim: Disease control
Last updated Apr 04, 2026 03:35 UTC
-
New hope for Tough-to-Treat ovarian cancer
Disease control CompletedThis study tested whether adding a new drug called relacorilant to standard chemotherapy could better control recurrent ovarian, fallopian tube, or primary peritoneal cancer that had stopped responding to platinum-based drugs. It involved 178 patients who were randomly assigned t…
Phase: PHASE2 • Sponsor: Corcept Therapeutics • Aim: Disease control
Last updated Apr 02, 2026 14:57 UTC
-
Hidden hormone link to stubborn high blood pressure investigated in major U.S. study
Knowledge-focused CompletedThis study aimed to find out how common a hidden hormone problem (called endogenous hypercortisolism) is in people whose high blood pressure does not respond well to multiple medications. Over 1,100 adults with this 'resistant hypertension' across the U.S. were enrolled. Research…
Sponsor: Corcept Therapeutics • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:39 UTC